Successful chemotherapy for newly diagnosed aggressive oligodendroglioma

Ann Neurol. 1990 May;27(5):573-4. doi: 10.1002/ana.410270519.

Abstract

We treated 3 patients with newly diagnosed aggressive oligodendroglioma with chemotherapy prior to radiotherapy and observed responses. All had residual or progressive tumor following initial surgery. We used a combination called PCV-3 because recurrent anaplastic oligodendroglioma responds predictably to this regimen. Chemotherapy for response induction followed by radiotherapy for consolidation is feasible and effective initial treatment for this tumor.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy
  • Female
  • Humans
  • Lomustine / adverse effects
  • Lomustine / therapeutic use*
  • Male
  • Middle Aged
  • Oligodendroglioma / diagnostic imaging
  • Oligodendroglioma / drug therapy*
  • Oligodendroglioma / radiotherapy
  • Procarbazine / adverse effects
  • Procarbazine / therapeutic use*
  • Tomography, X-Ray Computed
  • Vincristine / adverse effects
  • Vincristine / therapeutic use*

Substances

  • Procarbazine
  • Vincristine
  • Lomustine